Covetrus, Inc.
CVET · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/29/2018 | |
|---|---|---|---|---|
| Market Cap | $3 | $3 | $1 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $0 |
| Enterprise Value | $4 | $4 | $2 | $5 |
| Revenue | $5 | $4 | $4 | $4 |
| % Growth | 5.4% | 9.1% | 5.2% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 18.8% | 18.4% | 18.8% | 18.1% |
| EBITDA | $0 | $0 | -$1 | $0 |
| % Margin | 3.9% | 4.9% | -20% | 5.3% |
| Net Income | -$0 | -$0 | -$1 | $0 |
| % Margin | -1.9% | -0.4% | -25.6% | 2.7% |
| EPS Diluted | -0.63 | -0.16 | -9.52 | 0.91 |
| % Growth | -293.7% | 98.3% | -1,146.2% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | $0 |